News | February 17, 2024
Internal restructuring of foreign subsidiaries at Bliss GVS Pharma
The restructuring aims to create synergies across the business and strengthen capital structure
The restructuring aims to create synergies across the business and strengthen capital structure
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Subscribe To Our Newsletter & Stay Updated
